OraSure Technologies reported $222.94M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Agilent USD 4.76B 148M Mar/2026
AngioDynamics USD 161.35M 4.69M Sep/2025
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Bio Techne USD 688.05M 50.62M Mar/2026
Bio-Rad Laboratories USD 3.02B 78.4M Jun/2026
Bruker USD 2.22B 121.4M Jun/2026
Cerus USD 174.38M 7.26M Dec/2025
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Danaher USD 13.38B 554M Jun/2026
Dentsply International USD 1.93B 83M Jun/2026
Dexcom USD 4.09B 245.1M Jun/2026
Illumina USD 2.83B 96M Jun/2026
Integra LifeSciences USD 1.19B 19.46M Jun/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Mettler Toledo International USD 1.35B 15.48M Jun/2026
Myriad Genetics USD 289M 23.8M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Quidel USD 1.38B 400K Jun/2026
Repligen USD 1.2B 39.19M Jun/2026
Revvity USD 2.3B 169.4M Jun/2026
STAAR Surgical USD 342.35M 29.96M Jun/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
Trinity Biotech USD 35.9M 382K Dec/2025
Waters USD 3.9B 186M Jun/2026